Baby Genes

ArcherDx plans to keep its research and development efforts in its current facility and move its clinical and commercial testing operations to Baby Gene's CLIA lab.

Myriad Genetics said this week a top-five insurer has issued a positive medical policy decision for the Prolaris prostate cancer test. Myriad, through a spokesman, declined to identify the insurer.

Biosynth and Ramot announced this week that they have incorporated a joint venture called Nemis Technologies to jointly develop diagnostic kits and solutions for rapid pathogenic bacteria detection for food safety, water treatment, hospital, and clinical applications.